Current stage -Stage I Posts on Medivizor
Navigation Menu

Current stage -Stage I Posts on Medivizor

Evaluating image-guided irreversible electroporation of localized prostate cancer

Posted by on Jul 9, 2019 in Prostate cancer | 0 comments

In a nutshell This study aimed to evaluate the use of irreversible electroporation (IRE) in the treatment of prostate cancer. This study found that IRE had low side-effect rates and promising outcomes.  Some background Irreversible electroporation (IRE) uses high-energy pulses of electricity to destroy cancer cells. The brand name for...

Read More

Is vascular-targeted photodynamic therapy or active surveillance more effective in the treatment of low-risk prostate cancer?



Posted by on Apr 30, 2019 in Prostate cancer | 0 comments

In a nutshell This study examined if vascular-targeted photodynamic therapy (VTPT), or active surveillance is more effective in the treatment of low-risk prostate cancer. This study concluded that patients who received VTPT were less likely to require radical therapy compared to those who underwent active surveillance.  Some background...

Read More

Looking for patients with advanced prostate cancer to test a type of radiation therapy

Posted by on Feb 22, 2019 in Prostate cancer | 0 comments

In a nutshell This trial evaluates a specific type of radiation therapy for advanced prostate cancer. The main outcome to be measured is whether or not the therapy will damage the surrounding organs. This trial is taking place in Pennsylvania, USA.  The details Prostate cancer is an uncontrolled growth of the cells which make up the...

Read More

Long-term outcomes of active surveillance for localized prostate cancer.

Posted by on Jan 31, 2019 in Prostate cancer | 0 comments

In a nutshell This study aimed to investigate the outcomes of active surveillance (AS) in the treatment of localized prostate cancer. This study recommends the use of AS for men with localized prostate cancer. Some background Treatments for prostate cancer often result in serious side effects such as impaired bowel, bladder or sexual functions....

Read More

Long term results discussing radiotherapy and hormone therapy treatments for patients with prostate cancer

Posted by on Dec 16, 2018 in Prostate cancer | 0 comments

In a nutshell This study aimed to evaluate whole pelvic radiotherapy (WPRT) compared to prostate only radiotherapy (PORT) with hormonal therapy (HT) before or after radiation for patients with intermediate- or high-risk prostate cancer. This study found that HT before radiotherapy and WPRT had superior long-term survival without cancer growing or...

Read More

Is conventional or hypofractionated radiation therapy better for the treatment of prostate cancer?

Posted by on Nov 26, 2018 in Prostate cancer | 0 comments

In a nutshell This study compared two different types of radiation therapy after prostate surgery for prostate cancer, hypofractionated postprostatectomy radiation therapy (hypoPORT) and conventional postprostatectomy radiation therapy (coPORT). Results showed that hypoPORT may be effective in prostate cancer control and with similar side effects as...

Read More

Evaluating long-term outcomes of stereotactic body radiation therapy for low- and medium-risk prostate cancer

Posted by on Nov 13, 2018 in Prostate cancer | 0 comments

In a nutshell This study aimed to investigate the safety and effectiveness of stereotactic body radiation therapy (SBRT) as a treatment for prostate cancer. This study found that SBRT is a safe and effective option for low and medium risk prostate cancer. Some background Stereotactic body radiotherapy (SBRT) is a treatment option for...

Read More

Can men with low-risk prostate cancer on active surveillance be monitored only by PSA and MRI?

Posted by on Sep 7, 2018 in Prostate cancer | 0 comments

In a nutshell This study aimed to investigate if MRI scans (a test that takes detailed images of inside the body) could safely replace biopsies (samples taken from tissues for close examination) in active surveillance for prostate cancer. This study found that men with low-risk disease can be monitored using MRI and PSA levels with selective...

Read More

Are higher doses of radiation in less time better than conventional radiotherapy for prostate cancer?

Posted by on Sep 1, 2018 in Prostate cancer | 0 comments

In a nutshell This study aimed to investigate whether dose-escalated hypo-fractionated (higher doses in less time) radiation therapy would lead to better overall survival or less chance of cancer recurrence than the conventional method. They found that there is superior cancer control associated with dose-escalated hypo-fractionated radiation therapy for...

Read More